SCHEMBL3755156

SCHEMBL3755156

CC(C)(C)OC(=O)n1cc(I)c2ccncc21

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 1/20 0.40
MARK3 P27448 1/20 0.40
MAP4K2 Q12851 1/20 0.40
CAMK2B Q13554 1/20 0.40
PIM3 Q86V86 1/20 0.40
PIM2 Q9P1W9 1/20 0.40
ELANE P08246 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
HTR6 P50406 1/20 0.38
GABRG2 P18507 1/20 0.38
GABRB3 P28472 1/20 0.38
GABRA5 P31644 1/20 0.38
BCHE P06276 1/20 0.37
GPR119 Q8TDV5 6/20 0.36
HASPIN Q8TF76 1/20 0.35
KDM5A P29375 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31407790 1.00 PIM1 (0.40) PIM1MARK3MAP4K2CAMK2BPIM3
SCHEMBL1587770 0.89 PIM1 (0.42) PIM1MARK3MAP4K2CAMK2BPIM3
SCHEMBL31407376 0.89 PIM1 (0.42) PIM1MARK3MAP4K2CAMK2BPIM3
SCHEMBL3228084 0.85 L3MBTL1 (0.43) PIM1MARK3MAP4K2CAMK2BPIM3
SCHEMBL2112349 0.84 PIM1 (0.40) PIM1MARK3MAP4K2CAMK2BPIM3
SCHEMBL31330259 0.84 PIM1 (0.40) PIM1MARK3MAP4K2CAMK2BPIM3
SCHEMBL661642 0.83 L3MBTL1 (0.41) PIM1MARK3MAP4K2CAMK2BPIM3
SCHEMBL29951804 0.83 L3MBTL1 (0.41) PIM1MARK3MAP4K2CAMK2BPIM3
SCHEMBL13079979 0.82 L3MBTL1 (0.51) PIM1MARK3MAP4K2CAMK2BPIM3
SCHEMBL30940053 0.82 MEN1 (0.41) PIM1MARK3MAP4K2CAMK2BPIM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260015313-A1 AMINO ACID ACTIVE ESTER AND SALT THEREOF PEPTIDREAM INC (JP) 2026-01-15 US disclosed
US-20250296915-A1 NOVEL AMINO ACID DERIVATIVES PEPTIDREAM INC (JP) 2025-09-25 US disclosed
EP-4534524-A1 AMINO ACID ACTIVE ESTER AND SALT THEREOF PeptiDream Inc. (JP) 2025-04-09 EP disclosed
US-20240400499-A1 NOVEL AMINO ACID DERIVATIVES PEPTIDREAM INC (JP) 2024-12-05 US disclosed
US-20100292262-A1 4 (PYRROLO[2,3-C]PYRIDINE-3-YL)PYRIMIDIN-2-AMINE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2010-11-18 US disclosed
US-20100292262-A1 4 (PYRROLO[2,3-C]PYRIDINE-3-YL)PYRIMIDIN-2-AMINE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2010-11-18 US disclosed
US-20100292262-A1 4 (PYRROLO[2,3-C]PYRIDINE-3-YL)PYRIMIDIN-2-AMINE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2010-11-18 US disclosed
WO-2009092431-A1 4-(PYRROLO[2,3-C]PYRIDINE-3-YL)-PYRIMIDINE-2-AMINE DERIVATIVES MERCK PATENT GMBH (DE) 2009-07-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250296915-A1 NOVEL AMINO ACID DERIVATIVES DNPEP, BCAT1, ANPEP PIM1 1462/4885MARK3 3134/4885MAP4K2 1278/4885
US-20260015313-A1 AMINO ACID ACTIVE ESTER AND SALT THEREOF NSUN3, BCAT1, SLC43A1 PIM1 3012/4885MARK3 3261/4885MAP4K2 4328/4885
US-20100292262-A1 4 (PYRROLO[2,3-C]PYRIDINE-3-YL)PYRIMIDIN-2-AMINE DERIVATIVES MKI67, CDK4, CCNT1 PIM1 277/4885MARK3 2495/4885MAP4K2 619/4885
US-20240400499-A1 NOVEL AMINO ACID DERIVATIVES BCAT1, BCAT2, PELP1 PIM1 1857/4885MARK3 2861/4885MAP4K2 1943/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.